nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.317	1	CbGaD
Dihydrocodeine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0464	0.101	CbGbCtD
Dihydrocodeine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0458	0.0998	CbGbCtD
Dihydrocodeine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0428	0.0934	CbGbCtD
Dihydrocodeine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0408	0.089	CbGbCtD
Dihydrocodeine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0373	0.0814	CbGbCtD
Dihydrocodeine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0352	0.0767	CbGbCtD
Dihydrocodeine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0337	0.0735	CbGbCtD
Dihydrocodeine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0326	0.0711	CbGbCtD
Dihydrocodeine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0295	0.0643	CbGbCtD
Dihydrocodeine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0224	0.0488	CbGbCtD
Dihydrocodeine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0214	0.0467	CbGbCtD
Dihydrocodeine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0214	0.0467	CbGbCtD
Dihydrocodeine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0203	0.0442	CbGbCtD
Dihydrocodeine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0151	0.0329	CbGbCtD
Dihydrocodeine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0138	0.0301	CbGbCtD
Dihydrocodeine—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000385	0.00206	CcSEcCtD
Dihydrocodeine—Headache—Repaglinide—type 2 diabetes mellitus	0.000384	0.00205	CcSEcCtD
Dihydrocodeine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000384	0.00205	CcSEcCtD
Dihydrocodeine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000383	0.00205	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000383	0.00205	CcSEcCtD
Dihydrocodeine—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000382	0.00204	CcSEcCtD
Dihydrocodeine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000381	0.00204	CcSEcCtD
Dihydrocodeine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00038	0.00203	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000378	0.00202	CcSEcCtD
Dihydrocodeine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000376	0.00201	CcSEcCtD
Dihydrocodeine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000375	0.002	CcSEcCtD
Dihydrocodeine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000375	0.002	CcSEcCtD
Dihydrocodeine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000374	0.002	CcSEcCtD
Dihydrocodeine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000373	0.00199	CcSEcCtD
Dihydrocodeine—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000373	0.00199	CcSEcCtD
Dihydrocodeine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000372	0.00199	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000372	0.00199	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000369	0.00197	CcSEcCtD
Dihydrocodeine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000366	0.00195	CcSEcCtD
Dihydrocodeine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000365	0.00195	CcSEcCtD
Dihydrocodeine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000365	0.00195	CcSEcCtD
Dihydrocodeine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000365	0.00195	CcSEcCtD
Dihydrocodeine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000364	0.00195	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000363	0.00194	CcSEcCtD
Dihydrocodeine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000363	0.00194	CcSEcCtD
Dihydrocodeine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000361	0.00193	CcSEcCtD
Dihydrocodeine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000359	0.00192	CcSEcCtD
Dihydrocodeine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000358	0.00191	CcSEcCtD
Dihydrocodeine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000357	0.00191	CcSEcCtD
Dihydrocodeine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000355	0.0019	CcSEcCtD
Dihydrocodeine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000354	0.00189	CcSEcCtD
Dihydrocodeine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000354	0.00189	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000352	0.00188	CcSEcCtD
Dihydrocodeine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000352	0.00188	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000351	0.00188	CcSEcCtD
Dihydrocodeine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000351	0.00187	CcSEcCtD
Dihydrocodeine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000351	0.00187	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000349	0.00187	CcSEcCtD
Dihydrocodeine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000348	0.00186	CcSEcCtD
Dihydrocodeine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000347	0.00186	CcSEcCtD
Dihydrocodeine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000344	0.00184	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000344	0.00184	CcSEcCtD
Dihydrocodeine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000341	0.00182	CcSEcCtD
Dihydrocodeine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00034	0.00181	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000339	0.00181	CcSEcCtD
Dihydrocodeine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000338	0.00181	CcSEcCtD
Dihydrocodeine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000338	0.00181	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000337	0.0018	CcSEcCtD
Dihydrocodeine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000336	0.00179	CcSEcCtD
Dihydrocodeine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000335	0.00179	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000334	0.00178	CcSEcCtD
Dihydrocodeine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000333	0.00178	CcSEcCtD
Dihydrocodeine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000333	0.00178	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000331	0.00177	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00033	0.00176	CcSEcCtD
Dihydrocodeine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000329	0.00176	CcSEcCtD
Dihydrocodeine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000328	0.00175	CcSEcCtD
Dihydrocodeine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000325	0.00174	CcSEcCtD
Dihydrocodeine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000324	0.00173	CcSEcCtD
Dihydrocodeine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000323	0.00173	CcSEcCtD
Dihydrocodeine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000323	0.00172	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000322	0.00172	CcSEcCtD
Dihydrocodeine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000322	0.00172	CcSEcCtD
Dihydrocodeine—Rash—Glipizide—type 2 diabetes mellitus	0.00032	0.00171	CcSEcCtD
Dihydrocodeine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00032	0.00171	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000319	0.00171	CcSEcCtD
Dihydrocodeine—Headache—Glipizide—type 2 diabetes mellitus	0.000318	0.0017	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000316	0.00169	CcSEcCtD
Dihydrocodeine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000315	0.00168	CcSEcCtD
Dihydrocodeine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000313	0.00167	CcSEcCtD
Dihydrocodeine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000313	0.00167	CcSEcCtD
Dihydrocodeine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000313	0.00167	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000312	0.00167	CcSEcCtD
Dihydrocodeine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000312	0.00167	CcSEcCtD
Dihydrocodeine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000312	0.00167	CcSEcCtD
Dihydrocodeine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00031	0.00166	CcSEcCtD
Dihydrocodeine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00031	0.00166	CcSEcCtD
Dihydrocodeine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000309	0.00165	CcSEcCtD
Dihydrocodeine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000309	0.00165	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000308	0.00165	CcSEcCtD
Dihydrocodeine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000305	0.00163	CcSEcCtD
Dihydrocodeine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000305	0.00163	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000304	0.00162	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000303	0.00162	CcSEcCtD
Dihydrocodeine—Nausea—Glipizide—type 2 diabetes mellitus	0.000302	0.00161	CcSEcCtD
Dihydrocodeine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000301	0.00161	CcSEcCtD
Dihydrocodeine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000301	0.00161	CcSEcCtD
Dihydrocodeine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.0003	0.0016	CcSEcCtD
Dihydrocodeine—Constipation—Gliclazide—type 2 diabetes mellitus	0.0003	0.0016	CcSEcCtD
Dihydrocodeine—Rash—Glimepiride—type 2 diabetes mellitus	0.000299	0.0016	CcSEcCtD
Dihydrocodeine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000298	0.00159	CcSEcCtD
Dihydrocodeine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000298	0.00159	CcSEcCtD
Dihydrocodeine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000297	0.00159	CcSEcCtD
Dihydrocodeine—Headache—Glimepiride—type 2 diabetes mellitus	0.000297	0.00159	CcSEcCtD
Dihydrocodeine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000296	0.00158	CcSEcCtD
Dihydrocodeine—Oxymorphone—CYP3A4—type 2 diabetes mellitus	0.000294	0.129	CrCbGaD
Dihydrocodeine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000292	0.00156	CcSEcCtD
Dihydrocodeine—Angioedema—Losartan—type 2 diabetes mellitus	0.000292	0.00156	CcSEcCtD
Dihydrocodeine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000289	0.00155	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000289	0.00154	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000288	0.00154	CcSEcCtD
Dihydrocodeine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000287	0.00154	CcSEcCtD
Dihydrocodeine—Vertigo—Losartan—type 2 diabetes mellitus	0.000287	0.00153	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000287	0.00153	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000287	0.00153	CcSEcCtD
Dihydrocodeine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000287	0.00153	CcSEcCtD
Dihydrocodeine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000286	0.00153	CcSEcCtD
Dihydrocodeine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000285	0.00152	CcSEcCtD
Dihydrocodeine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000284	0.00152	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000284	0.00152	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000284	0.00152	CcSEcCtD
Dihydrocodeine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000283	0.00151	CcSEcCtD
Dihydrocodeine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000283	0.00151	CcSEcCtD
Dihydrocodeine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000281	0.0015	CcSEcCtD
Dihydrocodeine—Ethylmorphine—CYP3A4—type 2 diabetes mellitus	0.000281	0.123	CrCbGaD
Dihydrocodeine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000281	0.0015	CcSEcCtD
Dihydrocodeine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000279	0.00149	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000278	0.00149	CcSEcCtD
Dihydrocodeine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000277	0.00148	CcSEcCtD
Dihydrocodeine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000276	0.00148	CcSEcCtD
Dihydrocodeine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000276	0.00147	CcSEcCtD
Dihydrocodeine—Constipation—Valsartan—type 2 diabetes mellitus	0.000276	0.00147	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000275	0.00147	CcSEcCtD
Dihydrocodeine—Hypotension—Metformin—type 2 diabetes mellitus	0.000274	0.00147	CcSEcCtD
Dihydrocodeine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00145	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000272	0.00145	CcSEcCtD
Dihydrocodeine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00144	CcSEcCtD
Dihydrocodeine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00144	CcSEcCtD
Dihydrocodeine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000269	0.00144	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000268	0.00143	CcSEcCtD
Dihydrocodeine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000268	0.00143	CcSEcCtD
Dihydrocodeine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000267	0.00143	CcSEcCtD
Dihydrocodeine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000266	0.00142	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000264	0.00141	CcSEcCtD
Dihydrocodeine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000264	0.00141	CcSEcCtD
Dihydrocodeine—Confusional state—Losartan—type 2 diabetes mellitus	0.000263	0.0014	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000262	0.0014	CcSEcCtD
Dihydrocodeine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000262	0.0014	CcSEcCtD
Dihydrocodeine—Somnolence—Metformin—type 2 diabetes mellitus	0.000261	0.00139	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00026	0.00139	CcSEcCtD
Dihydrocodeine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000259	0.00138	CcSEcCtD
Dihydrocodeine—Hydrocodone—CYP3A4—type 2 diabetes mellitus	0.000257	0.113	CrCbGaD
Dihydrocodeine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000256	0.00137	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000256	0.00137	CcSEcCtD
Dihydrocodeine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000255	0.00136	CcSEcCtD
Dihydrocodeine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000254	0.00136	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000253	0.00135	CcSEcCtD
Dihydrocodeine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000253	0.00135	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000252	0.00135	CcSEcCtD
Dihydrocodeine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000252	0.00135	CcSEcCtD
Dihydrocodeine—Constipation—Metformin—type 2 diabetes mellitus	0.000251	0.00134	CcSEcCtD
Dihydrocodeine—Angioedema—Ramipril—type 2 diabetes mellitus	0.00025	0.00134	CcSEcCtD
Dihydrocodeine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000249	0.00133	CcSEcCtD
Dihydrocodeine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000248	0.00133	CcSEcCtD
Dihydrocodeine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000248	0.00133	CcSEcCtD
Dihydrocodeine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000247	0.00132	CcSEcCtD
Dihydrocodeine—Rash—Glyburide—type 2 diabetes mellitus	0.000246	0.00132	CcSEcCtD
Dihydrocodeine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000246	0.00132	CcSEcCtD
Dihydrocodeine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000246	0.00132	CcSEcCtD
Dihydrocodeine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000246	0.00131	CcSEcCtD
Dihydrocodeine—Headache—Glyburide—type 2 diabetes mellitus	0.000245	0.00131	CcSEcCtD
Dihydrocodeine—Hypotension—Losartan—type 2 diabetes mellitus	0.000244	0.0013	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000242	0.00129	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP2E1—type 2 diabetes mellitus	0.000242	0.106	CrCbGaD
Dihydrocodeine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00024	0.00128	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00024	0.00128	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000239	0.00128	CcSEcCtD
Dihydrocodeine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000237	0.00127	CcSEcCtD
Dihydrocodeine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000237	0.00127	CcSEcCtD
Dihydrocodeine—Oxycodone—CYP3A4—type 2 diabetes mellitus	0.000235	0.103	CrCbGaD
Dihydrocodeine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000234	0.00125	CcSEcCtD
Dihydrocodeine—Urticaria—Metformin—type 2 diabetes mellitus	0.000233	0.00125	CcSEcCtD
Dihydrocodeine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000232	0.00124	CcSEcCtD
Dihydrocodeine—Nausea—Glyburide—type 2 diabetes mellitus	0.000232	0.00124	CcSEcCtD
Dihydrocodeine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000232	0.00124	CcSEcCtD
Dihydrocodeine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000232	0.00124	CcSEcCtD
Dihydrocodeine—Somnolence—Losartan—type 2 diabetes mellitus	0.000232	0.00124	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000232	0.00124	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000228	0.00122	CcSEcCtD
Dihydrocodeine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000228	0.00122	CcSEcCtD
Dihydrocodeine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000228	0.00122	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000226	0.00121	CcSEcCtD
Dihydrocodeine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000225	0.0012	CcSEcCtD
Dihydrocodeine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000225	0.0012	CcSEcCtD
Dihydrocodeine—Codeine—CYP3A4—type 2 diabetes mellitus	0.000224	0.0981	CrCbGaD
Dihydrocodeine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000223	0.00119	CcSEcCtD
Dihydrocodeine—Constipation—Losartan—type 2 diabetes mellitus	0.000223	0.00119	CcSEcCtD
Dihydrocodeine—Rash—Gliclazide—type 2 diabetes mellitus	0.000221	0.00118	CcSEcCtD
Dihydrocodeine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000221	0.00118	CcSEcCtD
Dihydrocodeine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000221	0.00118	CcSEcCtD
Dihydrocodeine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00022	0.00118	CcSEcCtD
Dihydrocodeine—Headache—Gliclazide—type 2 diabetes mellitus	0.00022	0.00117	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000219	0.00117	CcSEcCtD
Dihydrocodeine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000219	0.00117	CcSEcCtD
Dihydrocodeine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000218	0.00116	CcSEcCtD
Dihydrocodeine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000217	0.00116	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000216	0.00115	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000215	0.00115	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000213	0.00114	CcSEcCtD
Dihydrocodeine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000213	0.00114	CcSEcCtD
Dihydrocodeine—Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.000213	0.0934	CrCbGaD
Dihydrocodeine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000211	0.00113	CcSEcCtD
Dihydrocodeine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000209	0.00112	CcSEcCtD
Dihydrocodeine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000208	0.00111	CcSEcCtD
Dihydrocodeine—Pruritus—Metformin—type 2 diabetes mellitus	0.000208	0.00111	CcSEcCtD
Dihydrocodeine—Urticaria—Losartan—type 2 diabetes mellitus	0.000207	0.00111	CcSEcCtD
Dihydrocodeine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000206	0.0011	CcSEcCtD
Dihydrocodeine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000205	0.0011	CcSEcCtD
Dihydrocodeine—Galantamine—CYP3A4—type 2 diabetes mellitus	0.000203	0.0891	CrCbGaD
Dihydrocodeine—Rash—Valsartan—type 2 diabetes mellitus	0.000203	0.00109	CcSEcCtD
Dihydrocodeine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000203	0.00108	CcSEcCtD
Dihydrocodeine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000202	0.00108	CcSEcCtD
Dihydrocodeine—Headache—Valsartan—type 2 diabetes mellitus	0.000202	0.00108	CcSEcCtD
Dihydrocodeine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000201	0.00107	CcSEcCtD
Dihydrocodeine—Rash—Orlistat—type 2 diabetes mellitus	0.000201	0.00107	CcSEcCtD
Dihydrocodeine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000201	0.00107	CcSEcCtD
Dihydrocodeine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000201	0.00107	CcSEcCtD
Dihydrocodeine—Headache—Orlistat—type 2 diabetes mellitus	0.0002	0.00107	CcSEcCtD
Dihydrocodeine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000199	0.00106	CcSEcCtD
Dihydrocodeine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000199	0.00106	CcSEcCtD
Dihydrocodeine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000196	0.00105	CcSEcCtD
Dihydrocodeine—Dizziness—Metformin—type 2 diabetes mellitus	0.000194	0.00104	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000193	0.00103	CcSEcCtD
Dihydrocodeine—Nausea—Valsartan—type 2 diabetes mellitus	0.000191	0.00102	CcSEcCtD
Dihydrocodeine—Constipation—Ramipril—type 2 diabetes mellitus	0.000191	0.00102	CcSEcCtD
Dihydrocodeine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00019	0.00101	CcSEcCtD
Dihydrocodeine—Nausea—Orlistat—type 2 diabetes mellitus	0.000189	0.00101	CcSEcCtD
Dihydrocodeine—Vomiting—Metformin—type 2 diabetes mellitus	0.000187	0.000997	CcSEcCtD
Dihydrocodeine—Rash—Metformin—type 2 diabetes mellitus	0.000185	0.000989	CcSEcCtD
Dihydrocodeine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000185	0.000988	CcSEcCtD
Dihydrocodeine—Pruritus—Losartan—type 2 diabetes mellitus	0.000184	0.000986	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000184	0.000984	CcSEcCtD
Dihydrocodeine—Headache—Metformin—type 2 diabetes mellitus	0.000184	0.000983	CcSEcCtD
Dihydrocodeine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000183	0.000979	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000183	0.000977	CcSEcCtD
Dihydrocodeine—Morphine—CYP3A4—type 2 diabetes mellitus	0.000181	0.0794	CrCbGaD
Dihydrocodeine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000178	0.000953	CcSEcCtD
Dihydrocodeine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000178	0.000949	CcSEcCtD
Dihydrocodeine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000177	0.000944	CcSEcCtD
Dihydrocodeine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000176	0.000941	CcSEcCtD
Dihydrocodeine—Rash—Irbesartan—type 2 diabetes mellitus	0.000175	0.000933	CcSEcCtD
Dihydrocodeine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000174	0.000932	CcSEcCtD
Dihydrocodeine—Nausea—Metformin—type 2 diabetes mellitus	0.000174	0.000932	CcSEcCtD
Dihydrocodeine—Headache—Irbesartan—type 2 diabetes mellitus	0.000174	0.000927	CcSEcCtD
Dihydrocodeine—Dizziness—Losartan—type 2 diabetes mellitus	0.000172	0.000921	CcSEcCtD
Dihydrocodeine—Vomiting—Losartan—type 2 diabetes mellitus	0.000166	0.000886	CcSEcCtD
Dihydrocodeine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000165	0.000879	CcSEcCtD
Dihydrocodeine—Rash—Losartan—type 2 diabetes mellitus	0.000164	0.000878	CcSEcCtD
Dihydrocodeine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000164	0.000877	CcSEcCtD
Dihydrocodeine—Headache—Losartan—type 2 diabetes mellitus	0.000163	0.000873	CcSEcCtD
Dihydrocodeine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000158	0.000845	CcSEcCtD
Dihydrocodeine—Nausea—Losartan—type 2 diabetes mellitus	0.000155	0.000827	CcSEcCtD
Dihydrocodeine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000153	0.000817	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP3A4—type 2 diabetes mellitus	0.000152	0.0667	CrCbGaD
Dihydrocodeine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000148	0.00079	CcSEcCtD
Dihydrocodeine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000142	0.000759	CcSEcCtD
Dihydrocodeine—Rash—Ramipril—type 2 diabetes mellitus	0.000141	0.000753	CcSEcCtD
Dihydrocodeine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000141	0.000752	CcSEcCtD
Dihydrocodeine—Headache—Ramipril—type 2 diabetes mellitus	0.00014	0.000748	CcSEcCtD
Dihydrocodeine—Nausea—Ramipril—type 2 diabetes mellitus	0.000133	0.000709	CcSEcCtD
Dihydrocodeine—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	2.52e-05	0.000712	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.43e-05	0.000687	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.41e-05	0.000681	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	2.4e-05	0.000679	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.39e-05	0.000675	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.39e-05	0.000675	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.35e-05	0.000665	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.33e-05	0.000657	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.33e-05	0.000657	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.32e-05	0.000656	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.32e-05	0.000656	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.31e-05	0.000653	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.29e-05	0.000647	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	2.22e-05	0.000627	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	2.22e-05	0.000627	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.21e-05	0.000624	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	2.17e-05	0.000614	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	2.14e-05	0.000605	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.14e-05	0.000605	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	2.14e-05	0.000605	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	2.14e-05	0.000605	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	2.14e-05	0.000605	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	2.12e-05	0.0006	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	2.1e-05	0.000593	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	2.07e-05	0.000586	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	2.07e-05	0.000586	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	2.06e-05	0.000582	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	2.05e-05	0.000579	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	2.02e-05	0.00057	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.01e-05	0.000569	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	2.01e-05	0.000568	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2e-05	0.000565	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.99e-05	0.000562	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.97e-05	0.000558	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	1.96e-05	0.000553	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	1.96e-05	0.000553	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.93e-05	0.000545	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.92e-05	0.000541	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	1.91e-05	0.000539	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.86e-05	0.000527	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.86e-05	0.000526	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.86e-05	0.000526	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.83e-05	0.000518	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	1.82e-05	0.000515	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	1.82e-05	0.000515	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	1.82e-05	0.000515	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.81e-05	0.000511	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.8e-05	0.000509	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.8e-05	0.000509	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.77e-05	0.0005	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.76e-05	0.000498	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.76e-05	0.000498	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	1.75e-05	0.000493	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	1.75e-05	0.000493	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.74e-05	0.000492	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.74e-05	0.000491	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.74e-05	0.000491	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.69e-05	0.000478	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	1.68e-05	0.000475	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	1.68e-05	0.000475	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	1.65e-05	0.000466	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.65e-05	0.000465	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.65e-05	0.000465	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.64e-05	0.000464	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.63e-05	0.000461	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.62e-05	0.000459	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.62e-05	0.000459	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.62e-05	0.000459	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.61e-05	0.000456	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.61e-05	0.000456	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.59e-05	0.000448	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.58e-05	0.000447	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.57e-05	0.000444	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.53e-05	0.000431	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.51e-05	0.000426	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.48e-05	0.000419	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.48e-05	0.000419	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.45e-05	0.00041	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.45e-05	0.00041	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.43e-05	0.000404	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.4e-05	0.000396	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.4e-05	0.000396	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.4e-05	0.000396	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.4e-05	0.000396	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.4e-05	0.000396	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.4e-05	0.000396	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.39e-05	0.000393	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.38e-05	0.00039	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.38e-05	0.00039	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.38e-05	0.00039	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.38e-05	0.00039	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.37e-05	0.000387	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.37e-05	0.000387	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.37e-05	0.000386	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.36e-05	0.000384	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.36e-05	0.000383	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.35e-05	0.00038	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.33e-05	0.000374	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.32e-05	0.000374	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.32e-05	0.000373	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.3e-05	0.000369	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.28e-05	0.000362	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.28e-05	0.000362	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.27e-05	0.000358	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.25e-05	0.000353	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.24e-05	0.00035	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.23e-05	0.000348	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.19e-05	0.000336	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.19e-05	0.000336	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.19e-05	0.000336	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.19e-05	0.000335	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.17e-05	0.000329	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.15e-05	0.000324	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.14e-05	0.000323	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.14e-05	0.000323	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.14e-05	0.000322	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.12e-05	0.000318	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.12e-05	0.000318	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.1e-05	0.000312	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.1e-05	0.00031	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.1e-05	0.00031	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.1e-05	0.00031	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.1e-05	0.00031	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.1e-05	0.00031	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.09e-05	0.000308	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.09e-05	0.000307	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.08e-05	0.000306	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.08e-05	0.000306	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.08e-05	0.000305	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.07e-05	0.000302	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.06e-05	0.000301	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.06e-05	0.0003	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.06e-05	0.0003	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.06e-05	0.0003	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.06e-05	0.0003	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.06e-05	0.0003	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.06e-05	0.000299	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.05e-05	0.000296	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1e-05	0.000283	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.98e-06	0.000282	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9.83e-06	0.000278	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9.83e-06	0.000278	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9.83e-06	0.000278	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	9.65e-06	0.000273	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	9.56e-06	0.00027	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.46e-06	0.000267	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	9.36e-06	0.000265	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.34e-06	0.000264	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	9.06e-06	0.000256	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.02e-06	0.000255	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.02e-06	0.000255	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.02e-06	0.000255	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.02e-06	0.000255	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.99e-06	0.000254	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.91e-06	0.000252	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.89e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.89e-06	0.000251	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.76e-06	0.000248	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.76e-06	0.000247	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.72e-06	0.000246	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	8.67e-06	0.000245	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.65e-06	0.000244	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	8.53e-06	0.000241	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	8.53e-06	0.000241	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.32e-06	0.000235	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.04e-06	0.000227	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.95e-06	0.000225	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.95e-06	0.000225	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.51e-06	0.000212	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.48e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.35e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.35e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.35e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.35e-06	0.000208	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.31e-06	0.000207	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	7.22e-06	0.000204	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.21e-06	0.000204	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.17e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.17e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.17e-06	0.000203	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.12e-06	0.000201	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	7.01e-06	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7e-06	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.91e-06	0.000195	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.82e-06	0.000193	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.81e-06	0.000192	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.75e-06	0.000191	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.7e-06	0.000189	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.69e-06	0.000189	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.55e-06	0.000185	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.53e-06	0.000184	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.43e-06	0.000182	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.43e-06	0.000182	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.43e-06	0.000182	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.38e-06	0.00018	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.36e-06	0.00018	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.31e-06	0.000178	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.31e-06	0.000178	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.28e-06	0.000177	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.25e-06	0.000177	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.18e-06	0.000175	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.12e-06	0.000173	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	6.02e-06	0.00017	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.91e-06	0.000167	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.88e-06	0.000166	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.88e-06	0.000166	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.81e-06	0.000164	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.81e-06	0.000164	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.72e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.72e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.63e-06	0.000159	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.61e-06	0.000158	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.57e-06	0.000158	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.57e-06	0.000158	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.54e-06	0.000157	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.25e-06	0.000148	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.15e-06	0.000146	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.88e-06	0.000138	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.8e-06	0.000136	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.8e-06	0.000136	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.79e-06	0.000135	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.78e-06	0.000135	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.72e-06	0.000133	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.58e-06	0.000129	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.46e-06	0.000126	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.39e-06	0.000124	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.37e-06	0.000124	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.28e-06	0.000121	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.27e-06	0.000121	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.2e-06	0.000119	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.2e-06	0.000119	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.16e-06	0.000117	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.1e-06	0.000116	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.96e-06	0.000112	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.94e-06	0.000111	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.86e-06	0.000109	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.84e-06	0.000109	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.74e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.68e-06	0.000104	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.67e-06	0.000104	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.65e-06	0.000103	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.62e-06	0.000102	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.19e-06	9.02e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.13e-06	8.85e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.87e-06	8.11e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.75e-06	7.76e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.75e-06	7.76e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.51e-06	7.1e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.93e-06	5.46e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	3.57e-05	CbGpPWpGaD
